| 761498 | Avtozma | tocilizumab-anoh | CELLTRION, Inc. | 2 | None listed | Current release |
| 761485 | Avlayah | tividenofusp alfa-eknm | Denali Therapeutics Inc. | 1 | None listed | Current release |
| 761484 | Rybrevant Faspro | amivantamab and hyaluronidase-lpuj | Janssen Biotech, Inc. | 4 | None listed | Current release |
| 761473 | Nufymco | ranibizumab-leyk | Formycon AG | 2 | None listed | Current release |
| 761468 | Hepcludex | bulevirtide-gmod | Gilead Sciences, Inc. | 1 | None listed | Current release |
| 761467 | Keytruda Qlex | pembrolizumab and berahyaluronidase alfa-pmph | Merck Sharp & Dohme LLC | 2 | None listed | Current release |
| 761460 | Decnupaz | pivekimab sunirine-pvzy | AbbVie Inc. | 1 | None listed | Current release |
| 761458 | Exdensur | depemokimab-ulaa | GlaxoSmithKline LLC | 2 | None listed | Current release |
| 761457 | Oziltus | denosumab-mobz | Amneal Pharmaceuticals LLC | 1 | None listed | Current release |
| 761456 | Boncresa | denosumab-mobz | Amneal Pharmaceuticals LLC | 1 | None listed | Current release |
| 761451 | Saphnelo | anifrolumab-fnia | AstraZeneca AB | 2 | None listed | Current release |
| 761450 | Poherdy | pertuzumab-dpzb | Shanghai Henlius Biotech, Inc. | 1 | None listed | Current release |
| 761449 | Tyenne | tocilizumab-aazg | Fresenius Kabi USA, LLC | 2 | None listed | Current release |
| 761444 | Bildyos, Bilprevda | denosumab-nxxp | Shanghai Henlius Biotech, Inc. | 3 | None listed | Current release |
| 761440 | Blenrep | belantamab mafodotin-blmf | GlaxoSmithKline LLC | 1 | None listed | Current release |
| 761439 | Enoby, Xtrenbo | denosumab-qbde | Hikma Pharmaceuticals USA Inc. | 2 | None listed | Current release |
| 761436 | Bosaya, Aukelso | denosumab-kyqq | Biocon Biologics Inc. | 2 | None listed | Current release |
| 761434 | Voyxact | sibeprenlimab-szsi | Otsuka Pharmaceutical Company, Ltd. | 1 | None listed | Current release |
| 761432 | Enflonsia | clesrovimab-cfor | Merck Sharp & Dohme LLC | 1 | None listed | Current release |
| 761430 | Imaavy | nipocalimab-aahu | Janssen Biotech, Inc. | 2 | None listed | Current release |
| 761427 | Lerochol | lerodalcibep-liga | LIB Therapeutics, Inc. | 1 | None listed | Current release |
| 761425 | Pyzchiva | ustekinumab-ttwe | Samsung Bioepis Co., Ltd. | 1 | None listed | Current release |
| 761424 | Osvyrti, Jubereq | denosumab-desu | Accord BioPharma Inc. | 2 | None listed | Current release |
| 761420 | Avtozma | tocilizumab-anoh | CELLTRION, Inc. | 5 | None listed | Current release |
| 761419 | Starjemza | ustekinumab-hmny | Bio-Thera Solutions, Ltd. | 4 | None listed | Current release |
| 761416 | Ziihera | zanidatamab-hrii | Jazz Pharmaceuticals Ireland Limited | 1 | None listed | Current release |
| 761412 | Langlara | insulin glargine-aldy | Sunshine Lake Pharma Co., Ltd. | 1 | None listed | Current release |
| 761411 | Niktimvo | axatilimab-csfr | Incyte Corporation | 1 | None listed | Current release |
| 761406 | Yesintek | ustekinumab-kfce | Biocon Biologics Inc. | 4 | None listed | Current release |
| 761404 | Stoboclo, Osenvelt | denosumab-bmwo | CELLTRION, Inc. | 2 | None listed | Current release |
| 761400 | Lynozyfic | linvoseltamab-gcpt | Regeneron Pharmaceuticals, Inc. | 2 | None listed | Current release |
| 761399 | Omlyclo | omalizumab-igec | CELLTRION, Inc. | 3 | None listed | Current release |
| 761398 | Conexxence, Bomyntra | denosumab-bnht | Fresenius Kabi USA, LLC | 3 | None listed | Current release |
| 761394 | Datroway | datopotamab deruxtecan-dlnk | Daiichi Sankyo, Inc | 1 | None listed | Current release |
| 761392 | Ospomyv, Xbryk | denosumab-dssb | Samsung Bioepis Co., Ltd. | 2 | None listed | Current release |
| 761390 | Nemluvio | nemolizumab-ilto | Galderma Laboratories, L.P. | 1 | None listed | Current release |
| 761388 | Piasky | crovalimab-akkz | Genentech, Inc. | 1 | None listed | Current release |
| 761385 | Ponlimsi | denosumab-adet | Teva Pharmaceuticals, Inc. | 1 | None listed | Current release |
| 761384 | Emrelis | telisotuzumab vedotin-tllv | AbbVie Inc. | 2 | None listed | Current release |
| 761382 | Enzeevu | aflibercept-abzv | Sandoz Inc. | 2 | None listed | Current release |
| 761381 | Opdivo Qvantig | nivolumab and hyaluronidase-nvhy | Bristol-Myers Squibb Company | 2 | None listed | Current release |
| 761379 | Otulfi | ustekinumab-aauz | Fresenius Kabi USA, LLC | 4 | None listed | Current release |
| 761378 | Ahzantive | aflibercept-mrbb | Formycon AG | 2 | None listed | Current release |
| 761377 | Eydenzelt | aflibercept-boav | CELLTRION, Inc. | 2 | None listed | Current release |
| 761375 | Leqembi IQLIK | lecanemab-irmb | Eisai, Incorporated | 1 | None listed | Current release |
| 761373 | Pyzchiva | ustekinumab-ttwe | Samsung Bioepis Co., Ltd. | 5 | None listed | Current release |
| 761371 | Ocrevus Zunovo | ocrelizumab and hyaluronidase-ocsq | Genentech, Inc. | 1 | None listed | Current release |
| 761369 | Hympavzi | marstacimab-hncq | Pfizer Inc. | 4 | None listed | Current release |
| 761367 | Andembry | garadacimab-gxii | CSL Behring LLC | 2 | None listed | Current release |
| 761365 | Vyloy | zolbetuximab-clzb | Astellas Pharma US, Inc. | 2 | None listed | Current release |
| 761364 | Imuldosa | ustekinumab-srlf | Accord BioPharma Inc. | 3 | None listed | Current release |
| 761363 | Winrevair | sotatercept-csrk | Merck Sharp & Dohme LLC | 2 | None listed | Current release |
| 761362 | Jubbonti, Wyost | denosumab-bbdz | Sandoz Inc. | 2 | None listed | Current release |
| 761358 | Zymfentra | infliximab-dyyb | CELLTRION, Inc. | 2 | None listed | Current release |
| 761355 | Eylea HD | aflibercept | Regeneron Pharmaceuticals, Inc. | 1 | None listed | Current release |
| 761354 | Tofidence | tocilizumab-bavi | Biogen MA Inc. | 3 | None listed | Current release |
| 761352 | Bizengri | zenocutuzumab-zbco | Merus NV | 1 | None listed | Current release |
| 761350 | Opuviz | aflibercept-yszy | Samsung Bioepis Co., Ltd. | 1 | None listed | Current release |
| 761349 | Cosentyx | secukinumab | Novartis Pharmaceuticals Corporation | 1 | None listed | Current release |
| 761347 | Tecentriq Hybreza | atezolizumab and hyaluronidase-tqjs | Genentech, Inc. | 1 | None listed | Current release |
| 761346 | Hercessi | trastuzumab-strf | Accord BioPharma Inc. | 2 | None listed | Current release |
| 761345 | Elrexfio | elranatamab-bcmm | Pfizer Inc. | 2 | None listed | Current release |
| 761344 | Imdelltra | tarlatamab-dlle | Amgen Inc. | 2 | None listed | Current release |
| 761343 | Selarsdi | ustekinumab-aekn | Alvotech USA Inc. | 4 | None listed | Current release |
| 761342 | Talvey | talquetamab-tgvs | Janssen Biotech, Inc. | 2 | None listed | Current release |
| 761340 | Epysqli | eculizumab-aagh | Samsung Bioepis Co., Ltd. | 1 | None listed | Current release |
| 761339 | Veopoz | pozelimab-bbfg | Regeneron Pharmaceuticals, Inc. | 1 | None listed | Current release |
| 761338 | Steqeyma | ustekinumab-stba | CELLTRION, Inc. | 4 | None listed | Current release |
| 761336 | Anktiva | nogapendekin alfa inbakicept-pmln | Altor BioScience, LLC, an indirect wholly-owned subsidiary of ImmunityBio, Inc. | 1 | None listed | Current release |
| 761334 | Zynyz | retifanlimab-dlwr | Incyte Corporation | 1 | None listed | Current release |
| 761333 | Bkemv | eculizumab-aeeb | Amgen Inc. | 1 | None listed | Current release |
| 761331 | Wezlana | ustekinumab-auub | Amgen Inc. | 1 | None listed | Current release |
| 761328 | Beyfortus | nirsevimab-alip | Sanofi Vaccines US Inc. | 2 | None listed | Current release |
| 761326 | Awiqli | insulin icodec-abae | Novo Nordisk Inc. | 3 | None listed | Current release |
| 761325 | Merilog | insulin aspart-szjj | Sanofi-Aventis U.S. LLC | 2 | None listed | Current release |
| 761324 | Epkinly | epcoritamab-bysp | Genmab US, Inc. | 2 | None listed | Current release |
| 761322 | Tyruko | natalizumab-sztn | Sandoz Inc. | 1 | None listed | Current release |
| 761315 | Alhemo | concizumab-mtci | Novo Nordisk Inc. | 3 | None listed | Current release |
| 761312 | Lymphir | denileukin diftitox-cxdl | Citius Oncology, Inc. | 1 | None listed | Current release |
| 761310 | Elahere | mirvetuximab soravtansine-gynx | ImmunoGen, Inc. | 1 | None listed | Current release |